nodes	percent_of_prediction	percent_of_DWPC	metapath
Timolol—hypertension—adrenal gland cancer	0.673	1	CtDrD
Timolol—ABCB1—adrenal gland cancer	0.307	1	CbGaD
Timolol—ADRB3—brown adipose tissue—adrenal gland cancer	0.0115	0.684	CbGeAlD
Timolol—CYP2C19—urine—adrenal gland cancer	0.00238	0.142	CbGeAlD
Timolol—CYP2D6—urine—adrenal gland cancer	0.00139	0.0825	CbGeAlD
Timolol—ADRB1—cardiac atrium—adrenal gland cancer	0.000652	0.0388	CbGeAlD
Timolol—ABCB1—adrenal cortex—adrenal gland cancer	0.000264	0.0157	CbGeAlD
Timolol—ABCB1—gonad—adrenal gland cancer	0.000219	0.013	CbGeAlD
Timolol—ABCB1—pituitary gland—adrenal gland cancer	0.000213	0.0127	CbGeAlD
Timolol—ABCB1—adrenal gland—adrenal gland cancer	0.000191	0.0113	CbGeAlD
Timolol—ADRB3—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	0.000138	0.0408	CbGpPWpGaD
Timolol—ADRB2—Arf6 signaling events—TSHR—adrenal gland cancer	0.000136	0.0403	CbGpPWpGaD
Timolol—CYP2D6—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.000127	0.0375	CbGpPWpGaD
Timolol—ADRB2—GPCRs, Other—GNRHR—adrenal gland cancer	0.000119	0.0352	CbGpPWpGaD
Timolol—ADRB2—Arf6 trafficking events—TSHR—adrenal gland cancer	0.000108	0.0318	CbGpPWpGaD
Timolol—ADRB3—G alpha (s) signalling events—TSHR—adrenal gland cancer	8.53e-05	0.0252	CbGpPWpGaD
Timolol—ADRB1—Endothelin Pathways—GNAS—adrenal gland cancer	8.49e-05	0.0251	CbGpPWpGaD
Timolol—ADRB1—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	8.19e-05	0.0242	CbGpPWpGaD
Timolol—ADRB2—Calcium Regulation in the Cardiac Cell—KCNJ5—adrenal gland cancer	8.01e-05	0.0237	CbGpPWpGaD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	7.62e-05	0.0225	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—GNRHR—adrenal gland cancer	5.8e-05	0.0172	CbGpPWpGaD
Timolol—ADRB3—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	5.29e-05	0.0156	CbGpPWpGaD
Timolol—ADRB1—G alpha (s) signalling events—TSHR—adrenal gland cancer	5.06e-05	0.015	CbGpPWpGaD
Timolol—ADRB3—G alpha (s) signalling events—GNAS—adrenal gland cancer	4.96e-05	0.0147	CbGpPWpGaD
Timolol—ADRB2—G alpha (s) signalling events—TSHR—adrenal gland cancer	4.95e-05	0.0147	CbGpPWpGaD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	4.56e-05	0.0135	CbGpPWpGaD
Timolol—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	4.55e-05	0.0135	CbGpPWpGaD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	4.52e-05	0.0134	CbGpPWpGaD
Timolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	4.42e-05	0.0131	CbGpPWpGaD
Timolol—ADRB3—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	4.28e-05	0.0127	CbGpPWpGaD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	4.07e-05	0.012	CbGpPWpGaD
Timolol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	3.97e-05	0.0117	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—GNRH1—adrenal gland cancer	3.47e-05	0.0103	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—GNRHR—adrenal gland cancer	3.44e-05	0.0102	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—GNRHR—adrenal gland cancer	3.37e-05	0.00996	CbGpPWpGaD
Timolol—ADRB3—G alpha (s) signalling events—POMC—adrenal gland cancer	3.34e-05	0.00988	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—GNRHR—adrenal gland cancer	3.28e-05	0.0097	CbGpPWpGaD
Timolol—ADRB1—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	3.14e-05	0.00928	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—TSHR—adrenal gland cancer	3.1e-05	0.00916	CbGpPWpGaD
Timolol—ADRB2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	3.07e-05	0.00908	CbGpPWpGaD
Timolol—ADRB2—Arf6 signaling events—EGFR—adrenal gland cancer	3.02e-05	0.00893	CbGpPWpGaD
Timolol—ADRB2—Arf6 trafficking events—CTNNB1—adrenal gland cancer	3.01e-05	0.0089	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—GNRHR—adrenal gland cancer	2.98e-05	0.00881	CbGpPWpGaD
Timolol—ADRB1—G alpha (s) signalling events—GNAS—adrenal gland cancer	2.94e-05	0.00871	CbGpPWpGaD
Timolol—ADRB2—G alpha (s) signalling events—GNAS—adrenal gland cancer	2.88e-05	0.00852	CbGpPWpGaD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	2.71e-05	0.00801	CbGpPWpGaD
Timolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	2.65e-05	0.00784	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	2.64e-05	0.00782	CbGpPWpGaD
Timolol—ADRB1—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	2.54e-05	0.00752	CbGpPWpGaD
Timolol—ADRB2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	2.49e-05	0.00736	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	2.46e-05	0.00727	CbGpPWpGaD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	2.41e-05	0.00714	CbGpPWpGaD
Timolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	2.36e-05	0.00699	CbGpPWpGaD
Timolol—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	2.13e-05	0.0063	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—GNRH1—adrenal gland cancer	2.06e-05	0.0061	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—GNRH1—adrenal gland cancer	2.02e-05	0.00597	CbGpPWpGaD
Timolol—ADRB1—G alpha (s) signalling events—POMC—adrenal gland cancer	1.98e-05	0.00587	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—GNRH1—adrenal gland cancer	1.96e-05	0.00581	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—GNRHR—adrenal gland cancer	1.95e-05	0.00576	CbGpPWpGaD
Timolol—ADRB2—G alpha (s) signalling events—POMC—adrenal gland cancer	1.94e-05	0.00574	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—GNRHR—adrenal gland cancer	1.9e-05	0.00563	CbGpPWpGaD
Timolol—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	1.89e-05	0.00559	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—TSHR—adrenal gland cancer	1.84e-05	0.00544	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—GNAS—adrenal gland cancer	1.8e-05	0.00533	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—TSHR—adrenal gland cancer	1.8e-05	0.00532	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—GNRH1—adrenal gland cancer	1.78e-05	0.00528	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—GNRHR—adrenal gland cancer	1.77e-05	0.00523	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—GNRHR—adrenal gland cancer	1.76e-05	0.0052	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—TSHR—adrenal gland cancer	1.75e-05	0.00518	CbGpPWpGaD
Timolol—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	1.74e-05	0.00515	CbGpPWpGaD
Timolol—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	1.74e-05	0.00514	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—GNRHR—adrenal gland cancer	1.73e-05	0.00511	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—SH3KBP1—adrenal gland cancer	1.63e-05	0.00484	CbGpPWpGaD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	1.59e-05	0.00471	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—TSHR—adrenal gland cancer	1.59e-05	0.0047	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—ZNRF3—adrenal gland cancer	1.54e-05	0.00455	CbGpPWpGaD
Timolol—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	1.53e-05	0.00453	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	1.52e-05	0.00449	CbGpPWpGaD
Timolol—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	1.41e-05	0.00416	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—POMC—adrenal gland cancer	1.21e-05	0.00359	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—GNRH1—adrenal gland cancer	1.17e-05	0.00345	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—PRKACA—adrenal gland cancer	1.14e-05	0.00337	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—GNRH1—adrenal gland cancer	1.14e-05	0.00337	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—GNAS—adrenal gland cancer	1.07e-05	0.00316	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—CDC42—adrenal gland cancer	1.07e-05	0.00315	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—GNRH1—adrenal gland cancer	1.06e-05	0.00313	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—GNRH1—adrenal gland cancer	1.05e-05	0.00312	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—GNAS—adrenal gland cancer	1.05e-05	0.00309	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—GNRHR—adrenal gland cancer	1.04e-05	0.00309	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—TSHR—adrenal gland cancer	1.04e-05	0.00307	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—GNRH1—adrenal gland cancer	1.04e-05	0.00306	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—GNRHR—adrenal gland cancer	1.02e-05	0.00302	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—GNAS—adrenal gland cancer	1.02e-05	0.00301	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—TSHR—adrenal gland cancer	1.02e-05	0.00301	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SH3KBP1—adrenal gland cancer	9.7e-06	0.00287	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—CDC42—adrenal gland cancer	9.67e-06	0.00286	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—SPRY2—adrenal gland cancer	9.63e-06	0.00285	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SH3KBP1—adrenal gland cancer	9.49e-06	0.00281	CbGpPWpGaD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	9.45e-06	0.0028	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—TSHR—adrenal gland cancer	9.43e-06	0.00279	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TSHR—adrenal gland cancer	9.39e-06	0.00278	CbGpPWpGaD
Timolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	9.25e-06	0.00274	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—GNAS—adrenal gland cancer	9.24e-06	0.00274	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—TSHR—adrenal gland cancer	9.23e-06	0.00273	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ZNRF3—adrenal gland cancer	9.12e-06	0.0027	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ZNRF3—adrenal gland cancer	8.92e-06	0.00264	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MEN1—adrenal gland cancer	8.83e-06	0.00261	CbGpPWpGaD
Timolol—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	8.13e-06	0.00241	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	7.91e-06	0.00234	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	7.84e-06	0.00232	CbGpPWpGaD
Timolol—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	7.48e-06	0.00221	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SDHB—adrenal gland cancer	7.27e-06	0.00215	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—POMC—adrenal gland cancer	7.2e-06	0.00213	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SDHB—adrenal gland cancer	7.09e-06	0.0021	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—POMC—adrenal gland cancer	7.04e-06	0.00208	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—POMC—adrenal gland cancer	6.85e-06	0.00203	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PRKACA—adrenal gland cancer	6.77e-06	0.002	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PRKACA—adrenal gland cancer	6.74e-06	0.00199	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SDHB—adrenal gland cancer	6.68e-06	0.00198	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PRKACA—adrenal gland cancer	6.62e-06	0.00196	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—CDC42—adrenal gland cancer	6.32e-06	0.00187	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—GNRH1—adrenal gland cancer	6.25e-06	0.00185	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—POMC—adrenal gland cancer	6.22e-06	0.00184	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—CDC42—adrenal gland cancer	6.19e-06	0.00183	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—GNRH1—adrenal gland cancer	6.12e-06	0.00181	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—GNAS—adrenal gland cancer	6.04e-06	0.00179	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—GNAS—adrenal gland cancer	5.91e-06	0.00175	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	5.82e-06	0.00172	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—CDC42—adrenal gland cancer	5.74e-06	0.0017	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	5.72e-06	0.00169	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SPRY2—adrenal gland cancer	5.72e-06	0.00169	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CDC42—adrenal gland cancer	5.72e-06	0.00169	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—CDC42—adrenal gland cancer	5.62e-06	0.00166	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SPRY2—adrenal gland cancer	5.59e-06	0.00165	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TSHR—adrenal gland cancer	5.57e-06	0.00165	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IGF2—adrenal gland cancer	5.51e-06	0.00163	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—GNAS—adrenal gland cancer	5.49e-06	0.00162	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—GNAS—adrenal gland cancer	5.46e-06	0.00162	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TSHR—adrenal gland cancer	5.45e-06	0.00161	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—GNAS—adrenal gland cancer	5.37e-06	0.00159	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IGF1R—adrenal gland cancer	5.33e-06	0.00158	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	5.31e-06	0.00157	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MEN1—adrenal gland cancer	5.24e-06	0.00155	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	5.21e-06	0.00154	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MEN1—adrenal gland cancer	5.12e-06	0.00152	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SDHD—adrenal gland cancer	4.68e-06	0.00139	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—RRM1—adrenal gland cancer	4.68e-06	0.00139	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TERT—adrenal gland cancer	4.58e-06	0.00136	CbGpPWpGaD
Timolol—ABCB1—Metabolism—RRM1—adrenal gland cancer	4.57e-06	0.00135	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SDHD—adrenal gland cancer	4.57e-06	0.00135	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—RRM1—adrenal gland cancer	4.31e-06	0.00127	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SDHD—adrenal gland cancer	4.31e-06	0.00127	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	4.3e-06	0.00127	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	4.13e-06	0.00122	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—POMC—adrenal gland cancer	4.07e-06	0.0012	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PRKACA—adrenal gland cancer	4e-06	0.00118	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—BAD—adrenal gland cancer	3.99e-06	0.00118	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—POMC—adrenal gland cancer	3.98e-06	0.00118	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PRKACA—adrenal gland cancer	3.91e-06	0.00116	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—POMC—adrenal gland cancer	3.69e-06	0.00109	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—POMC—adrenal gland cancer	3.68e-06	0.00109	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—BRAF—adrenal gland cancer	3.63e-06	0.00107	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—POMC—adrenal gland cancer	3.61e-06	0.00107	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—EGFR—adrenal gland cancer	3.52e-06	0.00104	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—MED12—adrenal gland cancer	3.49e-06	0.00103	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	3.46e-06	0.00102	CbGpPWpGaD
Timolol—ABCB1—Metabolism—MED12—adrenal gland cancer	3.41e-06	0.00101	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CDC42—adrenal gland cancer	3.39e-06	0.001	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CDC42—adrenal gland cancer	3.32e-06	0.000982	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IGF2—adrenal gland cancer	3.27e-06	0.000967	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—GNAS—adrenal gland cancer	3.24e-06	0.000959	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—MED12—adrenal gland cancer	3.21e-06	0.00095	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IGF2—adrenal gland cancer	3.2e-06	0.000946	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—GNAS—adrenal gland cancer	3.17e-06	0.000938	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IGF1R—adrenal gland cancer	3.16e-06	0.000935	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.12e-06	0.000924	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IGF1R—adrenal gland cancer	3.09e-06	0.000915	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TERT—adrenal gland cancer	2.72e-06	0.000805	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TERT—adrenal gland cancer	2.66e-06	0.000788	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CTNNB1—adrenal gland cancer	2.62e-06	0.000776	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	2.55e-06	0.000754	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.49e-06	0.000737	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PRKACA—adrenal gland cancer	2.49e-06	0.000736	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—BAD—adrenal gland cancer	2.37e-06	0.0007	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	2.34e-06	0.000693	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—BAD—adrenal gland cancer	2.32e-06	0.000685	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—POMC—adrenal gland cancer	2.18e-06	0.000646	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—BRAF—adrenal gland cancer	2.16e-06	0.000638	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—POMC—adrenal gland cancer	2.13e-06	0.000632	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—BRAF—adrenal gland cancer	2.11e-06	0.000624	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—EGFR—adrenal gland cancer	2.09e-06	0.000618	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EGFR—adrenal gland cancer	2.08e-06	0.000615	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GNAS—adrenal gland cancer	2.06e-06	0.000611	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—EGFR—adrenal gland cancer	2.04e-06	0.000605	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	2.03e-06	0.000599	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.02e-06	0.000596	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GNAS—adrenal gland cancer	1.9e-06	0.000562	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	1.86e-06	0.000551	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TP53—adrenal gland cancer	1.75e-06	0.000516	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.56e-06	0.000461	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.52e-06	0.000451	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—POMC—adrenal gland cancer	1.39e-06	0.000411	CbGpPWpGaD
Timolol—ABCB1—Metabolism—POMC—adrenal gland cancer	1.36e-06	0.000401	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—POMC—adrenal gland cancer	1.28e-06	0.000378	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EGFR—adrenal gland cancer	1.23e-06	0.000365	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EGFR—adrenal gland cancer	1.21e-06	0.000357	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	1.11e-06	0.000328	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.08e-06	0.00032	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TP53—adrenal gland cancer	1.04e-06	0.000307	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	1.02e-06	0.000302	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TP53—adrenal gland cancer	1.01e-06	0.0003	CbGpPWpGaD
